The working group proposes the following working definition of atrial cardiomyopathy: ‘Any complex of structural, architectural, contractile or electrophysiological changes affecting the atria with the potential to produce clinically-relevant manifestations’
Diseases like a hypertension, heart failure, valvular, genetic,diabetes,
myocarditis ... or conditions (like alone AF, smoking, isolated atrial amyloidosis,ageing, endocrine abnormalities...) are known to induce or contribute to an atrial cardiomyopathy
EHRAS classification of atrial cardiomyopathy ( class/ histological characterisation)
I Morphological or molecular changes affecting ‘primarily’
the cardiomyocytes in terms of cell hypertrophy and
myocytolysis; no significant pathological tissue fibrosis
or other interstitial changes
II Predominantly fibrotic changes; cardiomyocytes show
normal appearance
III Combination of cardiomyocyte changes (e.g. cell hypertrophy,
myocytolysis) and fibrotic changes Alteration of
interstitial matrix without prominent
IV Collagen fibre accumulation
Iva Accumulation of amyloid
IVf Fatty infiltration
IVi Inflammatory cells
IVo Other interstitial alterations
Read more: A. Goette et al. / Journal of Arrhythmia 32 (2016) 247–278
Article EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyop...
Thanks both of you.... for nice elaborate answar. I think CMR is very important to diagnose these cardiomyopathies... Can these cardiomyopathy produce embolism without atrial fibrillation.